mdlinx mdlinx
Medical Student Articles on MDLinx
Print

Prevalence of Noncalcified Coronary Plaque in Patients With Calcium Score of 0: The Silent Enemy
Angiology, 04/27/2012

Koulaouzidis G et al. - Computer tomography coronary angiography could be of diagnostic value in symptomatic patients with multiple risk factors for coronary artery disease (CAD), even in the absence of CAC.

Methods
  • The authors evaluated the prevalence and degree of stenosis caused by NCAP in patients without coronary artery calcification (CAC).
  • A retrospective analysis of 447 symptomatic patients with 0 CAC score revealed negative CTCA in 400 (89.5%). Noncalcified coronary artery plaques were demonstrated in 47 (10.5%), with 4 presenting stenosis >50%.

Results
  • Patients with positive CTCA, compared to those with normal CTCA, had significantly higher mean age (56.2 years vs 50.6 years, P < .004) and higher pretest coronary artery disease (CAD) probability (26% vs 34%, P < .0001).
  • Noncalcified coronary artery plaque was predominantly developed in the proximal segment of the left anterior descending artery.
  • Noncalcified coronary artery plaque is present in up to 10% of patients with a CAC score of 0.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close